Pub. Date : 2010 Mar
PMID : 20203452
5 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | LDL-C goal attainment in patients who remain on atorvastatin or switch to equivalent or non-equivalent doses of simvastatin: a retrospective matched cohort study in clinical practice. | Simvastatin | component of oligomeric golgi complex 2 | Homo sapiens |
| 2 | Patients switched to an equivalent simvastatin dose had lower LDL-C levels and were more likely to achieve LDL-C targets than patients switched to a non-equivalent dose, suggesting physicians must consider dosage equivalence when switching statins, and should measure LDL-C and titrate statins as necessary to achieve LDL-C control. | Simvastatin | component of oligomeric golgi complex 2 | Homo sapiens |
| 3 | Patients switched to an equivalent simvastatin dose had lower LDL-C levels and were more likely to achieve LDL-C targets than patients switched to a non-equivalent dose, suggesting physicians must consider dosage equivalence when switching statins, and should measure LDL-C and titrate statins as necessary to achieve LDL-C control. | Simvastatin | component of oligomeric golgi complex 2 | Homo sapiens |
| 4 | Patients switched to an equivalent simvastatin dose had lower LDL-C levels and were more likely to achieve LDL-C targets than patients switched to a non-equivalent dose, suggesting physicians must consider dosage equivalence when switching statins, and should measure LDL-C and titrate statins as necessary to achieve LDL-C control. | Simvastatin | component of oligomeric golgi complex 2 | Homo sapiens |
| 5 | Patients switched to an equivalent simvastatin dose had lower LDL-C levels and were more likely to achieve LDL-C targets than patients switched to a non-equivalent dose, suggesting physicians must consider dosage equivalence when switching statins, and should measure LDL-C and titrate statins as necessary to achieve LDL-C control. | Simvastatin | component of oligomeric golgi complex 2 | Homo sapiens |